SCD and fatty liver disease: SREBP1C is the predominant regulator of de novo lipogenesis and regulates the expression of the key lipogenic genes of ACC1, FAS and SCD1. Increased expression of SREBP1C, ACC1, FAS and SCD1 promoted hepatic lipid accumulation and induced liver steatosis [29].